Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Search History:
Count: 468
Selected: 0
NCT IDTitle
NCT05807880Anlotinib, Penpulimab and Capecitabine in Recurrent/Metastatic Nasopharyngeal Carcinoma
NCT04236362A Study of TQB2450 Combined With Anlotinib in Subjects With Gynecological Cancer
NCT06829784TQC2731 Clinical Trial for the Treatment of Severe Asthma With Injection
NCT04275050A Study to Evaluate the Tolerance and Pharmacokinetics of TQB3303 Tablets
NCT05046847A Clinical Study to Evaluate the Tolerability and Pharmacokinetics of TQB3811 Tablets in Patients With Advanced Malignant Tumors
NCT06010537Contrast-enhanced Magnetic Resonance Imaging With Polysaccharide Superparamagnetic Iron Oxide Nanoparticle
NCT06146751A Novel Ferumoxytol-enhanced Cardiac Magnetic Resonance Imaging for the Detection of Intracardiac Thrombus
NCT05830500Study of Anlotinib in Patients With Advanced Medullary Thyroid Carcinoma
NCT05306847Sintilimab Combined With Anlotinib Therapy for Initially Unresectable Non-small Cell Lung Cancer
NCT04180150A Study of TQ-A3334 Combined With Entecavir in the Treatment of Chronic Hepatitis B
NCT07043725A Clinical Study of Neoadjuvant Treatment With TQB2102 for Injection for Human Epidermal Growth Factor Receptor 2 (HER2) Positive Breast Cancer
NCT06431438Study to Evaluate the Tolerability, Safety, Pharmacokinetics and Pharmacodynamics of TQA3810 Tablets
NCT02574819Study of Methylnaltrexone in Opioid-Induced Constipation Patients
NCT06211751A Clinical Trial of TQB3909 Tablets Combined With TQB3702 Tablets in Patients With Hematologic Malignancy
NCT07608666Study to Evaluate the Effect of Rabeprazole Sodium Enteric-coated Tablets on the Pharmacokinetics of TQ05105 Tablets
NCT07047365TQB2930 Injection for the Treatment of HER2-positive Advanced Breast Cancer
NCT05559242Pharmacokinetic Study of Anlotinib Hydrochloride Capsules in Healthy Subjects and Liver Dysfunction Patients
NCT03986073Study of TQ-F3083 Capsules in Subjects With Type 2 Diabetes Mellitus
NCT06008405Clinical Trial Evaluating the Safety of the TQB2928 Injection Combination Therapy
NCT06542614Treatment of Moderate to Severe Plaque Psoriasis
NCT04278820A Study of TQA3526 in the Treatment of Primary Biliary Cirrhosis (PBC)
NCT07179679A Clinical Study Assessing the Subcutaneous Formulation of TQB2934 for Injection in Subjects With Malignant Plasma Cell Tumors
NCT07113925A Clinical Trial Evaluating TQB2101 in Subjects With Advanced Hematologic Malignancies
NCT04619563A Trial of Anlotinib Combined With Docetaxel in EGFR Mutations Advanced Non Small Cell Lung Cancer Patients
NCT04854668A Study of Anlotinib Hydrochloride Capsule Combined With Chemotherapy as First-line Treatment in Subjects With RAS/BRAF Wild Metastatic Colorectal Cancer
NCT03778138Study of Anlotinib Combined With Pemetrexed in Patients With Advanced Nonsquamous NSCLC
NCT02996838A Phase I Study of TQ-B3234 on Tolerance and Pharmacokinetics
NCT04073537Study of Anlotinib Hydrochloride Capsule Combined With Chemotherapy in Subjects With Squamous Non-small Cell Lung Cancer
NCT05192512Clinical Trial of the TQB2928 Injection in Patients With Advanced Cancers
NCT03983928Study of TQB2450 Combined With Anlotinib in the Treatment of Mutation Positive Lung Cancer
NCT03855358A Study of TQB2450 Injection and Anlotinib Hydrochloride Capsules to Treat Triple Negative Breast Cancer (TNBC)
NCT06024915A Study to Evaluate Drug-Drug Interaction of TQ05105 Tablets
NCT04623333A Study of TQB2450 Injection in Subjects With PD-L1 Positive Recurrent or Metastatic Cervical Cancer
NCT06051565Cardiovascular Contrast-enhanced Magnetic Resonance Imaging Using Polysaccharide Superparamagnetic Iron Oxide Injection in Diabetic Patients
NCT05021367A Clinical Study of TQB3823 in Patients With Advanced Malignant Tumor
NCT03457844A Study of Anlotinib in Patients With Gastroenteropancreatic Neuroendocrine Tumor G3
NCT07367529A Clinical Trial on the Efficacy and Safety of TQB6411 for Injection
NCT06415903A Clinical Trial of TQB3117 Tablets in Patients With Advanced Malignant Cancer
NCT06821503Clinical Study Evaluating the Safety, Tolerability, and Preliminary Efficacy of LM-108 ± Penpulimab+Chemotherapy in Advanced Solid Tumors - Cohort C
NCT07083739A Study on the Safety and Efficacy of TQB3473 Tablets in the Treatment of Persistent or Chronic Primary Immune Thrombocytopenia (ITP) in Adults
NCT06768619Bioequivalence Study of Eltrombopag Olamine Tablets in Healthy Subjects in the Fed State
NCT04956328Study of Obeticholic Acid(OCA) Combination With Ursodeoxycholic Acid (UDCA) in Patients With Primay Biliary Cirrhosis (PBC)
NCT06931145Benmelstobart, Anlotinib and Chemotherapy as First-line Treatment for Extensive-stage Small-cell Lung Cancer
NCT06561607A Clinical Trial of TQB2102 for Injection in the Treatment of HER2 Low-Expressing Recurrent/Metastatic Breast Cancer
NCT07633314A Clinical Trial Comparing TQC3927 Inhaled Powder With Glycopyrronium Bromide and Formoterol Inhaled Aerosol (Biovoping® Lingchang®) for the Treatment of Chronic Obstructive Pulmonary Disease
NCT03855384Study of TQB2450 in Patients With Recurrent or Metastatic Squamous Cell Cancer of the Head and Neck(R/M SCCHN)
NCT05780567Clinical Study on Adjuvant Therapy of TQB3616 Combined With Endocrine Therapy Compared With Placebo Combined With Endocrine Therapy in Patients With Breast Cancer
NCT07708272QT Interval/Corrected QT Interval (QT/QTc) Clinical Study to Evaluate the Cardiac Safety of TQ05105 Tablets in Healthy Participants
NCT02388919Study of Anlotinib in Patients With Advanced Non-small Cell Lung Cancer(ALTER0303)
NCT04923607Phase I Clinical Trial of TQC2731 Injection